GENTAMICIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gentamicin Sulfate, and when can generic versions of Gentamicin Sulfate launch?
Gentamicin Sulfate is a drug marketed by Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Padagis Us, Pharmaderm, Taro, Abbott, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, Wyeth Ayerst, Fera Pharms Llc, Sciegen Pharms Inc, Encube, Alcon Pharms Ltd, Bausch And Lomb, Epic Pharma Llc, Paco, Sandoz, B Braun, and Baxter Hlthcare. and is included in forty NDAs.
The generic ingredient in GENTAMICIN SULFATE is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gentamicin Sulfate
A generic version of GENTAMICIN SULFATE was approved as gentamicin sulfate by SANDOZ on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GENTAMICIN SULFATE?
- What are the global sales for GENTAMICIN SULFATE?
- What is Average Wholesale Price for GENTAMICIN SULFATE?
Summary for GENTAMICIN SULFATE
| US Patents: | 0 |
| Applicants: | 27 |
| NDAs: | 40 |
| Finished Product Suppliers / Packagers: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 13 |
| Patent Applications: | 361 |
| DailyMed Link: | GENTAMICIN SULFATE at DailyMed |
Recent Clinical Trials for GENTAMICIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oslo University Hospital | Phase 1/Phase 2 |
| Kaiser Permanente | Phase 2 |
| University of California, San Diego | Phase 2 |
Pharmacology for GENTAMICIN SULFATE
| Drug Class | Aminoglycoside Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for GENTAMICIN SULFATE
US Patents and Regulatory Information for GENTAMICIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | gentamicin sulfate | INJECTABLE;INJECTION | 062373-003 | Sep 7, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cosette | GENTAMICIN SULFATE | gentamicin sulfate | OINTMENT;TOPICAL | 064054-001 | Apr 29, 1994 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Parenteral | GENTAMICIN SULFATE | gentamicin sulfate | INJECTABLE;INJECTION | 063149-001 | Nov 21, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | gentamicin sulfate | INJECTABLE;INJECTION | 062588-005 | Jan 6, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | GENTAMICIN SULFATE | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 062635-001 | Jan 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun | GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | gentamicin sulfate | INJECTABLE;INJECTION | 062814-008 | Aug 28, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
